Table 1 The expected physicochemical properties and drug-likeness for substances 4, 6, 8, and 10 compared to forxiga and acarbose.
From: Dual α-amylase and α-glucosidase inhibition by 1,2,4-triazole derivatives for diabetes treatment
Compounds | a M.W. (g/mol) | b iLog Po/w | c Log S | d TPSA (Å) | e HBA | f HBD | g NRB | Lipinski violations |
|---|---|---|---|---|---|---|---|---|
4 | 472.56 | 3.96 | −5.41 | 111.41 | 5 | 1 | 10 | 0 |
6 | 474.53 | 3.53 | − 5.33 | 131.64 | 6 | 2 | 10 | 0 |
8 | 502.58 | 4.28 | −5.77 | 120.64 | 6 | 1 | 12 | 1 |
10 | 509.42 | 4.59 | −6.37 | 94.34 | 4 | 1 | 9 | 2 |
Forxiga | 408.87 | 2.18 | −3.78 | 99.38 | 6 | 4 | 6 | 0 |
Acarbose | 645.60 | −6.67 | 2.57 | 329.01 | 19 | 14 | 13 | 3 |